Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06179290 · ClinicalTrials.gov registry record · NA
Changes in Biomarker of Exposure in Adults Who Smoke Cigarettes Switching From Cigarettes to Heated Tobacco Products
A NA study of Tobacco Use, sponsored by Altria Client Services.
- Completed
- Registry status
- NA
- Development phase
- 921
- Enrollment target
- 7
- Study locations
NCT06179290: Completed NA study of Tobacco Use, sponsored by Altria Client Services.
NCT06179290 is a NA study of Tobacco Use that has completed, run by Altria Client Services. The registered enrollment target is 921 participants, above the 367-participant average among 76 other Tobacco Use trials with a reported enrollment target (151% higher). The trial reports 7 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06179290, a NA study of Tobacco Use, has completed, sponsored by Altria Client Services.
- COMPLETED
- Registry status
- NA
- Development phase
- 921 participants
- Enrollment target
- 7
- Study locations
Study Summary
The purpose of the study is to evaluate changes in biomarkers of exposure (BoE) to harmful and potentially harmful constituents (HPHCs) in adult smokers who completely switch to Ploom heated tobacco products (HTPs) compared to those who continue to smoke usual brand combustible cigarettes (UBCC).
Primary Outcome
Total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine adjusted for urine creatinine (pg/mg creatinine)
Conditions Studied
Interventions
- OTHER Ploom HTP Menthol HTS; MX3 (681)
- OTHER Ploom HTP Tobacco HTS; R8 (120)
- OTHER Smoking Abstinence (menthol)
- OTHER Smoking Abstinence (non-menthol)
Study Locations (7)
Arkansas
- Woodland Research Northwest - Rogers
Kansas
- Dr. Vince Clinical Research, LLC - Overland Park
Kentucky
- Alliance for Multispecialty Research, LLC - Lexington
Missouri
- QPS Bio-Kinetic - Springfield
Nebraska
- Celerion Lincoln - Lincoln
Tennessee
- Alliance for Multispecialty Research, LLC - Knoxville
Wisconsin
- Spaulding Clinical Research - West Bend
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 921 participants |
| Start Date | 2023-10-02 |
| Est. Completion | 2025-03-24 |
| Phase | NA |
What the finished NCT06179290 record still lists
NCT06179290 is an interventional study that assigns participants to a tested intervention. The registered 921 participants enrollment target is mid-sized for trials with a published cap, above the 367-participant average among 76 other Tobacco Use trials with a reported enrollment target (151% higher).
The record links to 1 condition, with Tobacco Use appearing as the primary indexed condition, and to 4 interventions - of which Ploom HTP Menthol HTS; MX3 (681) is the first listed.
NCT06179290 lists 7 locations in 7 states (Arkansas, Kansas, Kentucky).
Frequently Asked Questions
What is clinical trial NCT06179290 about?
NCT06179290 is a clinical study titled "Changes in Biomarker of Exposure in Adults Who Smoke Cigarettes Switching From Cigarettes to Heated Tobacco Products". The purpose of the study is to evaluate changes in biomarkers of exposure (BoE) to harmful and potentially harmful constituents (HPHCs) in adult smokers who completely switch to Ploom heated tobacco products (HTPs) compared to those who continue to smoke usual brand combustible cigarettes (UBCC).
What is the current status of trial NCT06179290?
This trial is currently completed. It is a NA study. The enrollment target is 921 participants. The study started on 2023-10-02. Estimated completion is 2025-03-24.
What conditions does trial NCT06179290 study?
This clinical trial studies the following conditions: Tobacco Use.
What interventions are being tested in trial NCT06179290?
The interventions under investigation include: Ploom HTP Menthol HTS; MX3 (681) (OTHER), Ploom HTP Tobacco HTS; R8 (120) (OTHER), Smoking Abstinence (menthol) (OTHER), Smoking Abstinence (non-menthol) (OTHER).
Who is sponsoring clinical trial NCT06179290?
This trial is sponsored by Altria Client Services, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06179290 being conducted?
This trial has 7 study locations across Arkansas, Kansas, Kentucky, Missouri, Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06179290's enrollment target sits among peer trials
921 7th of 76 higher than 70 of 76 other Tobacco Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tobacco Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux
RECRUITING · NA
-
Opioids, Low Nicotine Cigarettes, and Chronic Pain
RECRUITING · NA
-
Reach Through Equitable Implementation in Utah
RECRUITING · NA
-
RTMS Targets Neural Circuits for Smoking Cessation
RECRUITING · NA
-
Cigar Legislation and Regulation in Tobacco for the Young (Project CLARITY)
RECRUITING · NA
-
Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07151001 · 922 participants
Pivotal Trial of Automated Artificial Intelligence (AI) Based System for Early Diagnosis of Diabetic Retinopathy
- NCT04589845 · 920 participants · Phase 2
Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study
- NCT06109870 · 920 participants · NA
Prevención en Sus Manos: Feasibility of a Novel Community-Based Strategy to Improve Access to Cervical Cancer Screening
- NCT06957366 · 920 participants · NA
Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI